Anti-drug Antibody (ADA) Assays

Unwanted immunogenicity is an immune response by an organism against a therapeutic antigen. This reaction leads to the production of anti-drug antibodies (ADAs). ADA assays are designed to detect and quantify antibodies produced by patients in response to the administered drug. These assays help identify if a drug is immunogenic and if patients are developing antibodies that may impact drug efficacy and safety. Understanding immunogenicity helps researchers and clinicians make informed decisions about dosing regimens, patient management, and risk mitigation strategies. Mercodia has a proven track record in developing and validating assays for the detection of ADAs. We are GLP approved and work in accordance with regulatory guidelines, ICH GCP, EMA, and FDA.